TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $4

Benzinga Newsdesk www.benzinga.com Positive 73.0%

Neg 0% Neu 0% Pos 73%

TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $3 to $4.